PT-141

Overview

PT-141 (Bremelanotide) is a synthetic research peptide derived from the peptide hormone Melanotan II. It is widely studied in laboratory environments for its potential to modulate melanocortin receptors, which are involved in pathways related to sexual behavior and arousal in preclinical models such as laboratory rodents.

Benefits

Preclinical studies suggest that PT-141 may help stimulate the melanocortin system, promoting increased sexual arousal and libido-like responses in test subjects. Unlike other pathways that affect vascular systems, PT-141 acts directly on the nervous system, making it a unique research compound for investigating sexual function and behavior.
Source: Diamond LE, et al. Double-blind, placebo-controlled evaluation of the safety and efficacy of PT-141 in male subjects with erectile dysfunction. Journal of Sexual Medicine, 2004.

Possible Side Effects

In laboratory settings, test subjects administered PT-141 have demonstrated mild side effects such as facial flushing, temporary nausea-like responses, and injection site irritation. Additional observations have included transient changes in blood pressure and mild headache-like responses depending on dosage and frequency.
Source: Diamond LE, et al., Journal of Sexual Medicine, 2004.

Dosage & Administration

PT-141 is typically administered via subcutaneous injection under approved laboratory protocols. Typical research dosages range from 0.5 mg to 2 mg per injection, with frequency varying depending on study design, species, and desired research outcomes.
For laboratory research use only. Not for human consumption.

Summary

PT-141 is a synthetic melanocortin receptor agonist peptide developed exclusively for laboratory research on sexual function and arousal pathways in preclinical models. Research suggests it may help stimulate sexual behavior-like responses with mild side effects such as flushing or injection site irritation occasionally observed in test subjects. PT-141 is administered via subcutaneous injection with dosage and frequency tailored to each research study.
Strictly for research purposes only. Not for human use.